| | Drug Preparedness and Response to Bioterrorism |
 | | FDA announces conditions under which Prussian blue can be found safe and effective for the treatment of internal contamination with radioactive cesium, radioactive thallium, or non-radioactive thallium. |
 | | FDA has approved new dosage forms of the Atropen for use in children and adolescents exposed to certain nerve agents or insecticides. |
 | | FDA approves a New Drug Application for Radiogardase, also known as Prussian blue, to treat people exposed to radiation contamination, due to harmful levels of cesium-137 or thallium. |
| www.fda.gov /cder/drugprepare (1256 words) |